Evidence map›Paper›PMID 33897629›Full record

ArticleFrontiers in microbiology2021

Phenotypic and Genomic Variability of Serial Peri-Lung Transplantation

Rucha Datar, Andreu Coello Pelegrin, Sylvain Orenga, Valérie Chalansonnet, Caroline Mirande, Jill Dombrecht, John D Perry, Audrey Perry, Herman Goossens, Alex van Belkum

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Variable phage susceptibility ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genome Analysis ofPathogens (Basel, Switzerland) · 2023
    Article
  10. In host evolution of beta lactam resistance during active treatment forFrontiers in cellular and infection microbiology · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Rucha DatarBioMérieux, La Balme les Grottes, France.
Andreu Coello PelegrinBioMérieux, La Balme les Grottes, France.
Sylvain OrengaBioMérieux, La Balme les Grottes, France.
Valérie ChalansonnetBioMérieux, La Balme les Grottes, France.
Caroline MirandeBioMérieux, La Balme les Grottes, France.
Jill DombrechtApplied Maths, BioMérieux, Sint-Martens-Latem, Belgium.
John D PerryFreeman Hospital, Newcastle upon Tyne, United Kingdom.
Audrey PerryFreeman Hospital, Newcastle upon Tyne, United Kingdom.
Herman GoossensLaboratory of Medical Microbiology, Faculty of Medicine and Health Sciences, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Alex van BelkumBioMérieux, La Balme les Grottes, France.
bioMérieux (France) · FRFreeman Hospital · GBUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) represents one of the major genetic and chronic lung diseases affecting Caucasians of European descent. Patients with CF suffer from recurring infections that lead to further damage of the lungs. Pulmonary infection due to

Indexed as

antimicrobial resistancecystic fibrosislung transplantationPseudomonas aeruginosawhole genome sequencing

Identifiers

PMID33897629
PMCPMC8058383
OpenAlexW3149862046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.